Journal Home
Search for

Volume 20, Issue 1, Pages 74-81 (January 2010)


View previous. 13 of 17 View next.

Is Green Tea Drinking Associated With a Later Onset of Breast Cancer?

Qi DaiaCorresponding Author Informationemail address, Xiao-Ou Shua, Honglan Lib, Gong Yanga, Martha J. Shrubsolea, Hui Caia, Butian Jid, Wanqing Wena, Adrian Frankec, Yu-Tang Gaob, Wei Zhenga

Received 30 April 2009; accepted 9 September 2009.

Background

Studies have found that tea polyphenols inhibit aromatase. Because of the substantial difference in levels of estrogens between premenopausal and postmenopausal women, the relationship between tea consumption and breast cancer risk may depend on menopausal status.

Methods

We examined this hypothesis in the Shanghai Women's Health Study, a population-based cohort study of 74,942 Chinese women.

Results

We found a time-dependent interaction between green tea consumption and age of breast cancer onset (p for interaction, 0.03). In comparison with non-tea drinkers, women who started tea-drinking at 25 years of age or younger had a hazard ratio (HR) of 0.69 (95% confidence interval [CI]: 0.41–1.17) to develop premenopausal breast cancer. On the other hand, compared with non-tea drinkers, women who started tea drinking at 25 years of age or younger had an increased risk of postmenopausal breast cancer with an HR of 1.61 (95% CI: 1.18–2.20). Additional analyses suggest regularly drinking green tea may delay the onset of breast cancer.

Conclusions

Further studies are needed to confirm our findings.

Selected Abbreviations and AcronymsEGCG, epigallocatechin gallate, SWHS, Shanghai Women's Health Study

a Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt School of Medicine, Nashville, TN

b Department of Epidemiology, Shanghai Cancer Institute, Shanghai 200032, People's Republic of China

c Cancer Research Center of Hawaii, Honolulu

d Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD

Corresponding Author InformationAddress correspondence to: Dr. Qi Dai, Vanderbilt Epidemiology Center, Institute for Medicine & Public Health, Sixth Floor, Suite 600, 2525 West End Ave., Nashville, TN 37203-1738. Tel: (615) 936-0707; fax: 615-936-8291.

PII: S1047-2797(09)00317-2

doi:10.1016/j.annepidem.2009.09.005


View previous. 13 of 17 View next.